Cargando…
Prognostic gene expression assays in breast cancer: are two better than one?
Autor principal: | Sparano, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964115/ https://www.ncbi.nlm.nih.gov/pubmed/29845110 http://dx.doi.org/10.1038/s41523-018-0063-9 |
Ejemplares similares
-
Is one better than two?
por: Kim, Tae-Il
Publicado: (2013) -
Two are Better Than One: Valuing Medical Friendship
por: Davidson, John H., et al.
Publicado: (2015) -
The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes
por: Barbi, Mali, et al.
Publicado: (2021) -
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
por: Page, David B., et al.
Publicado: (2019) -
Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
por: Silver, Richard T.
Publicado: (2020)